Comparing our data with the acute tolerance threshold of 17 SvRBE5 reported in Kratochwil et al. (8, 18), we did not expect to find a high-grade xerostomia incidence in our treatment for 100 kBq/kg 225Ac-PSMA injected activity. This evidence concerns the gene FOLH1 and xerostomia.